• Israel, first vaccine dose to about one third of the population

Share

01 February 2021 Biontech wants to increase its production capacity by more than 50% in 2021, compared to what has been planned so far, reaching 2 billion doses.

This was announced by the German house in Mainz.

So far, the company had planned 1.3 billion doses.

"We are on track to expand production capabilities," said the group.